Fintel reports that on June 21, 2024, Needham initiated coverage of ICU Medical (NasdaqGS:ICUI) with a Hold recommendation.
Analyst Price Forecast Suggests 19.48% Upside
As of June 12, 2024, the average one-year price target for ICU Medical is 138.72. The forecasts range from a low of 136.35 to a high of $143.85. The average price target represents an increase of 19.48% from its latest reported closing price of 116.10.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for ICU Medical is 2,544MM, an increase of 12.71%. The projected annual non-GAAP EPS is 10.05.
What is the Fund Sentiment?
There are 564 funds or institutions reporting positions in ICU Medical. This is an decrease of 54 owner(s) or 8.74% in the last quarter. Average portfolio weight of all funds dedicated to ICUI is 0.14%, an increase of 16.84%. Total shares owned by institutions decreased in the last three months by 0.86% to 28,754K shares. 
The put/call ratio of ICUI is 1.06, indicating a bearish outlook.
What are Other Shareholders Doing?
Janus Henderson Group holds 2,471K shares representing 10.14% ownership of the company. In its prior filing, the firm reported owning 2,618K shares , representing a decrease of 5.93%. The firm decreased its portfolio allocation in ICUI by 66.51% over the last quarter.
Fuller & Thaler Asset Management holds 1,535K shares representing 6.30% ownership of the company. In its prior filing, the firm reported owning 1,472K shares , representing an increase of 4.08%. The firm decreased its portfolio allocation in ICUI by 3.40% over the last quarter.
Wellington Management Group Llp holds 1,379K shares representing 5.66% ownership of the company. In its prior filing, the firm reported owning 1,575K shares , representing a decrease of 14.23%. The firm decreased its portfolio allocation in ICUI by 87.28% over the last quarter.
IJR - iShares Core S&P Small-Cap ETF holds 1,374K shares representing 5.64% ownership of the company. In its prior filing, the firm reported owning 1,357K shares , representing an increase of 1.28%. The firm increased its portfolio allocation in ICUI by 4.40% over the last quarter.
UBVLX - Undiscovered Managers Behavioral Value Fund Class L holds 1,285K shares representing 5.28% ownership of the company. In its prior filing, the firm reported owning 1,230K shares , representing an increase of 4.32%. The firm increased its portfolio allocation in ICUI by 0.39% over the last quarter.
ICU Medical Background Information
(This description is provided by the company.)
ICU Medical, Inc. develops, manufactures and sells innovative medical products used in infusion therapy and critical care applications. ICU Medical's product portfolio includes IV smart pumps, sets, connectors, closed system transfer devices for hazardous drugs, sterile IV solutions, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. ICU Medical is headquartered in San Clemente, California.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
